You are here

Clinical Trials: Bone Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: 06/06/2017 - 19:00
Condition:   Osteonecrosis of Femoral Head
Interventions:   Drug: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#);   Procedure: core decompression
Sponsor:   Sclnow Biotechnology Co., Ltd.
Not yet recruiting - verified May 2017
Posted: 04/19/2017 - 19:00
Conditions:   Osteopenia;   Osteoporosis;   Osteonecrosis
Interventions:   Drug: LLP2A-ALENDRONATE;   Drug: Placebo
Sponsors:   Nancy E. Lane, MD;   California Institute for Regenerative Medicine
Recruiting - verified June 2017
Posted: 02/08/2017 - 20:00
Condition:   Spondylolisthesis
Interventions:   Biological: NVD-001;   Procedure: Standard of Care
Sponsor:   Novadip Biosciences
Recruiting - verified March 2017
Posted: 12/10/2016 - 20:00
Condition:   Lumbar Disc Herniation
Interventions:   Device: Autologous Bone Marrow Stem Cell (BMSC)/gelatin sponge;   Procedure: The defect is sutured
Sponsor:   Zhang Kaihui
Recruiting - verified December 2016
Posted: 07/27/2016 - 19:00
Condition:   Osteonecrosis
Interventions:   Drug: Ferumoxytol-enhanced magnetic resonance imaging;   Device: Magentic Resonance Imaging
Sponsor:   Stanford University
Recruiting - verified September 2016
Posted: 04/18/2016 - 19:00
Conditions:   Alveolar Bone Loss;   Atrophy
Interventions:   Procedure: BFPSC+FDBA+PRF;   Procedure: FDBA+PRF
Sponsor:   Shahid Beheshti University of Medical Sciences
Recruiting - verified April 2016
Posted: 04/18/2016 - 19:00
Condition:   Alveolar Bone Loss
Interventions:   Procedure: BFPSCs+ DFDBA+ PRF;   Procedure: DFDBA + PRF
Sponsor:   Shahid Beheshti University of Medical Sciences
Recruiting - verified April 2016
Posted: 12/09/2015 - 20:00
Conditions:   Spondylosis;   Spondylolisthesis;   Degenerative Disc Disease
Intervention:   Device: map3® Cellular Allogeneic Bone Graft
Sponsor:   RTI Surgical
Recruiting - verified February 2016
Posted: 07/04/2015 - 19:00
Conditions:   Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions:   Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
Sponsor:   King Edward Medical University
Not yet recruiting - verified July 2015
Posted: 03/25/2015 - 19:00
Condition:   Degenerative Disc Disease
Interventions:   Drug: rexlemestrocel-L;   Drug: rexlemestrocel-L + HA;   Drug: Placebo
Sponsors:   Mesoblast, Ltd.;   Quintiles, Inc.
Recruiting - verified February 2016

Pages